Breast Cancer Clinical Trial
— APAPIOfficial title:
Active Early Individualized Psychosocial Accompaniment to Facilitate the Return to Employment of Women With Breast Cancer
| NCT number | NCT01780064 |
| Other study ID # | APAPI-1202 |
| Secondary ID | |
| Status | Terminated |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | February 2013 |
| Est. completion date | January 2018 |
| Verified date | June 2024 |
| Source | Centre Oscar Lambret |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to compare the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work
| Status | Terminated |
| Enrollment | 128 |
| Est. completion date | January 2018 |
| Est. primary completion date | December 2015 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Women = 18 with work at the time of diagnosis - Presenting a unilateral breast cancer exclusively local extension - Having received surgery - Reporting of adjuvant chemotherapy (+ / - trastuzumab) - Reporting to radiotherapy or not (If radiotherapy, it will be done on site investigator) - In work at the time of diagnosis (employees, traders and professionals) - Patient affiliated to a social security scheme - Consent signed by the patient before the implementation of any specific procedure to study Exclusion Criteria: - Presence of in situ lesions, cancer recurrence, metastatic disease immediately, location bilateral - Inability physical, psychological, psychiatric or cognitive responses to the questionnaires and participate in interviews - Recognition previous ALD (due to another disease) - Patient under guardianship |
| Country | Name | City | State |
|---|---|---|---|
| France | Centre Marie Curie | Arras | |
| France | Centre Pierre Curie | Beuvry | |
| France | Centre Léonard de Vinci | Dechy | |
| France | Centre Oscar Lambret | Lille | |
| France | Centre Hospitalier | Valenciennes | |
| France | Nouvelle Clinique des Dentellières | Valenciennes | |
| France | Hôpital Privé de Villeneuve d'Ascq | Villeneuve d'Ascq |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Oscar Lambret | University Hospital, Lille |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Comparison of the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work | At 24 months | ||
| Secondary | Comparison between the two modes of care, of social inequalities: | On the quality of the return to employment (working conditions, job stability)
On individual and collective resources of patients (social encouragement received, reactions to issues, anxiety/depression, quality of life, etc) |
At 24 months | |
| Secondary | Calculating the cost / benefit ratio of the two modes of care | At 24 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |